TickerLeague

Free Cash Flow for Bristol-Myers Squibb (BMY)

Free Cash Flow for Bristol-Myers Squibb (BMY): headline value $12.85B · YoY -7.9%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$12.85B

YoY change

-7.9%

5Y CAGR

-0.7%

Peak year (2021)

$15.23B

Latest annual

$12.85B

Free Cash Flow history chart for Bristol-Myers Squibb (BMY) from 1989 to 2025

Free Cash Flow history table for Bristol-Myers Squibb (BMY) from 1989 to 2025

Fiscal yearPeriod endedReportedFree Cash FlowYoY
2025$12.85B-7.9%
2024$13.94B+10.2%
2023$12.65B+5.9%
2022$11.95B-21.6%
2021$15.23B+14.5%
2020$13.30B+80.3%
2019$7.37B+20.6%
2018$6.12B+44.9%
2017$4.22B+129.0%
2016$1.84B+43.4%
2015$1.28B-51.0%
2014$2.62B-12.8%
2013$3.01B-52.9%
2012$6.39B+42.9%
2011$4.47B+10.0%
2010$4.07B+21.9%
2009$3.33B+20.6%
2008$2.77B+19.7%
2007$2.31B+79.1%
2006$1.29B+20.8%
2005$1.07B-54.9%
2004$2.37B-6.1%
2003$2.52B-1164.1%
2002-$237.00M-105.4%
2001$4.38B+7.8%
2000$4.06B+15.6%
1999$3.52B+17.4%
1998$2.99B+75.2%
1997$1.71B-16.2%
1996$2.04B+2.7%
1995$1.99B+14.9%
1994$1.73B-14.0%
1993$2.01B+45.5%
1992$1.38B+14.4%
1991$1.21B-2.6%
1990$1.24B+95.1%
1989$635.00M

Free Cash Flow values are taken from Bristol-Myers Squibb's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

The 2025 reading of Bristol-Myers Squibb (BMY) free cash flow is $12.85B – declined 7.9% year-over-year.

Bristol-Myers Squibb free cash flow compound annual growth for the 2020–2025 (5 years) window is -0.7%, with a net decline across the window.

Bristol-Myers Squibb free cash flow peaked at $15.23B in 2021; the latest annual figure is $12.85B in 2025 (15.7% below peak).

2021 marks the peak free cash flow at $15.23B, with the historical low of -$237.00M recorded in 2002.

Among 8 Healthcare peers, Bristol-Myers Squibb (BMY) ranks 5th; the peer median for free cash flow is $14.22B.

Bristol-Myers Squibb Free Cash Flow by Year

Bristol-Myers Squibb Free Cash Flow 2025: $12.85B

Bristol-Myers Squibb free cash flow in 2025 was $12.85B, declined 7.9% below 2024.

Bristol-Myers Squibb Free Cash Flow 2024: $13.94B

Bristol-Myers Squibb free cash flow in 2024 was $13.94B, grew 10.2% from 2023.

Bristol-Myers Squibb Free Cash Flow 2023: $12.65B

Bristol-Myers Squibb free cash flow in 2023 was $12.65B, grew 5.9% from 2022.

Bristol-Myers Squibb Free Cash Flow 2022: $11.95B

Bristol-Myers Squibb free cash flow in 2022 was $11.95B, declined 21.6% below 2021.

Bristol-Myers Squibb Free Cash Flow 2021: $15.23B

Bristol-Myers Squibb free cash flow in 2021 was $15.23B.

See more financial history for Bristol-Myers Squibb (BMY).

Sector peers — Free Cash Flow

Companies in the same sector as Bristol-Myers Squibb, ranked by their latest free cash flow.

CompanyFree Cash FlowSector
Novo Nordisk A/S (NVO)$28.99BHealthcare
Johnson & Johnson (JNJ)$19.70BHealthcare
AbbVie Inc. (ABBV)$17.82BHealthcare
UnitedHealth Group Incorporated (UNH)$16.07BHealthcare
Merck & Co., Inc. (MRK)$12.36BHealthcare
AstraZeneca PLC (AZN)$11.77BHealthcare
Eli Lilly and Company (LLY)$8.97BHealthcare
Amgen Inc. (AMGN)$8.10BHealthcare

Frequently asked questions

What is Bristol-Myers Squibb's free cash flow?

Latest reported free cash flow for Bristol-Myers Squibb (BMY) is $12.85B (period ending December 31, 2025).

How has Bristol-Myers Squibb free cash flow changed year-over-year?

Bristol-Myers Squibb (BMY) free cash flow changed -7.9% year-over-year on the latest annual filing.

What is the long-term growth rate of Bristol-Myers Squibb free cash flow?

Bristol-Myers Squibb (BMY) free cash flow compound annual growth rate is -0.7% over the most recent 5 years available.

When did Bristol-Myers Squibb free cash flow hit its highest annual value?

Bristol-Myers Squibb free cash flow reached its highest annual value of $15.23B in 2021.

What was Bristol-Myers Squibb free cash flow in 2024?

Bristol-Myers Squibb (BMY) free cash flow in 2024 was $13.94B.

What was Bristol-Myers Squibb free cash flow in 2025?

Bristol-Myers Squibb (BMY) free cash flow in 2025 was $12.85B.

Metrics overview

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.